Medicare Enrolled

Dr. Rajamurugan Subramaniyam

Pulmonary Disease · Springfield, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
800 E CARPENTER ST, Springfield, IL 62769
2175446464
In practice since 2016 (9 years)
NPI: 1245783257 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Subramaniyam from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Subramaniyam? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Subramaniyam

Dr. Rajamurugan Subramaniyam is a pulmonary disease specialist in Springfield, IL, with 9 years of NPI registration. Based on federal Medicare data, Dr. Subramaniyam performed 854 Medicare services across 508 unique beneficiaries.

Between the years covered by Open Payments, Dr. Subramaniyam received a total of $3,291 from 18 pharmaceutical and/or device companies across 50 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Subramaniyam is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 45% volume in IL $3,291 industry payments

Medicare Practice Summary

Medicare Utilization ↗
854
Medicare services
Top 45% in IL for pulmonary disease
508
Unique beneficiaries
$139
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
 600 $166 $523
Insertion of non-tunneled central venous catheter
A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin.
 88 $66 $806
Arterial line insertion
A tube is inserted into an artery through the skin to allow for blood sampling or infusion.
 56 $35 $180
Additional 30 minutes of critical care
This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period.
 54 $84 $237
Emergent tracheostomy
An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope.
 33 $112 $391
Bronchial secretion aspiration via endoscope
Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus.
 12 $113 $1,032
Manual attempt to restore blood circulation and breathing
A manual procedure performed to restore blood circulation and breathing.
 11 $143 $748
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.3% high complexity
0.0% medium
89.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,291
Total received (2019-2024)
Avg $658/year across 5 years
Top 38% in IL for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
50
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,291 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$349
2023
$485
2022
$326
2021
$722
2019
$1,408

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$182
Janssen Pharmaceuticals, Inc
$123
Electromed, Inc.
$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Top 3 companies account for 94.6% of 2024 payments
All-time payments by company (2019-2024) ›
GENZYME CORPORATION
$719
AstraZeneca Pharmaceuticals LP
$469
Genentech USA, Inc.
$358
Merck Sharp & Dohme Corporation
$214
AbbVie Inc.
$197
ABBVIE INC.
$182
Janssen Pharmaceuticals, Inc
$177
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
Takeda Pharmaceuticals U.S.A., Inc.
$123
GlaxoSmithKline, LLC.
$122
Mylan Specialty L.P.
$119
Actelion Pharmaceuticals US, Inc.
$105
PFIZER INC.
$102
Penumbra, Inc.
$87
La Jolla Pharmaceutical Company
$79
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$53
Electromed, Inc.
$25
Novartis Pharmaceuticals Corporation
$20
Top 3 companies account for 47.0% of all-time payments
Associated products mentioned in payments ›
AVYCAZ · BREZTRI · DALVANCE · DUPIXENT · ENTRESTO · FASENRA · GIAPREZA · GLASSIA · JARDIANCE · NUCALA · Penumbra System · SMARTVEST · TEFLARO · TEZSPIRE · UPTRAVI · XARELTO · XELJANZ · XIFAXAN · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Springfield?
Compare pulmonary diseases in the Springfield area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Subramaniyam is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Subramaniyam experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Subramaniyam performed 600 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Subramaniyam receive payments from pharmaceutical companies?
Yes. Dr. Subramaniyam received a total of $3,291 from 18 companies across 50 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Subramaniyam's costs compare to other pulmonary diseases in Springfield?
Dr. Subramaniyam's average Medicare payment per service is $139. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Subramaniyam) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Springfield
Browse pulmonary diseases in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in IL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in IL
Which IL pulmonary diseases receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →